Pharma Journalist -

Biogen. Inc. and Ionis Pharmaceuticals, Inc. announced that topline data from a Phase 1b placebo-controlled, multiple ascending dose clinical study showed that BIIB080/IONIS-MAPTRx met…
Read More...

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases…
Read More...

Nexus Pharmaceuticals announced the launch of Potassium Chloride in Water for Injection in 10mEq/100mL, 10mEq/50mL, and 20mEq/50mL Single-Dose IV bags. “Nexus is proud…
Read More...

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes…
Read More...

Sun Pharmaceutical Industries Ltd. "Sun Pharma" and includes its subsidiaries and/or associate companies) and Cassiopea SpA, a specialty pharmaceutical company developing and preparing…
Read More...

Alexion’s Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for expanded use to include children and adolescents with paroxysmal…
Read More...

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients,…
Read More...

Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of Canada and the Canadian Institutes of Health Research, published as a pre-print,…
Read More...

ImaginAb Inc, a market leading global biotechnology company, focused on developing next generation immuno oncology imaging agents and therapeutic radiopharmaceuticals (RPT), announced…
Read More...

Acorda Therapeutics, Inc. announced that it has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A (ESTEVE) to commercialize INBRIJA 33 mg (levodopa…
Read More...